| 注册
首页|期刊导航|肿瘤药学|miRNA 在卵巢癌中作用的研究进展

miRNA 在卵巢癌中作用的研究进展

唐雁 王静 罗晨辉 赵敏 赵雪蘅 钟晶敏

肿瘤药学Issue(4):241-245,5.
肿瘤药学Issue(4):241-245,5.DOI:10.3969/j.issn.2095-1264.2015.04.01

miRNA 在卵巢癌中作用的研究进展

The Research Progress of miRNA in Ovarian Cancer

唐雁 1王静 2罗晨辉 2赵敏 3赵雪蘅 1钟晶敏2

作者信息

  • 1. 南华大学,湖南 衡阳,421001
  • 2. 中南大学湘雅医学院附属肿瘤医院,湖南 长沙,410013
  • 3. 中南大学湘雅医院临床药理研究所,湖南 长沙,410008
  • 折叠

摘要

Abstract

Ovarian cancer is one of gynecologic malignancies with the highest mortality and the worst prognosis. Cur-rently, it may be mainly due to the lacking of effective methods for early diagnosis and chemotherapy resistance. MicroRNA, a short non-coding sequence of an endogenous small RNA, can get involved in regulating cell growth, proliferation and apoptosis, mainly through degrading or inhibiting the target genes at the post-transcriptional level. According to some stud-ies, some of the tumor-associated microRNAs play an important role in the development, invasion and metastasis of ovarian cancer by regulating the expression of a variety of oncogenes and tumor suppressor genes in vivo. Meanwhile, there is a close relationship between the differential expression of special microRNAs and the drug resistance and prognosis of ovarian can-cer. Thus, making clear of the target genes and associated regulation pathways of the ovarian cancer-related microRNAs is of great significance for improvement of diagnosis and treatment on ovarian cancer. In this paper, we mainly reviewed the roles of microRNAs in ovarian cancer.

关键词

miRNA/卵巢癌/增殖与凋亡

Key words

miRNA/Ovarian cancer/Apoptosis and proliferation

分类

医药卫生

引用本文复制引用

唐雁,王静,罗晨辉,赵敏,赵雪蘅,钟晶敏..miRNA 在卵巢癌中作用的研究进展[J].肿瘤药学,2015,(4):241-245,5.

基金项目

湖南省科技厅重点项目资助(2013FJ2009)。 ()

肿瘤药学

OACSTPCD

2095-1264

访问量3
|
下载量0
段落导航相关论文